Harrison Hamblin graduated from the University of NSW in 2018 with a degree in Medical Science. In the first three years following, he was deeply engaged in clinical research, focusing on innovative treatments for chronic gastrointestinal infections like Crohn’s disease, Ulcerative colitis, IBS, and Clostridioides difficile infection through Faecal transplant therapy. Harrison’s dedication during this time led to the publication of four full-text research papers and an invitation to co-author an international review on novel therapies for Crohn’s Disease. Additionally, he has shared his insights through numerous abstract presentations at international Gastroenterology conferences. Currently, Harrison is continuing his medical education in his third year at Notre Dame’s Wagga Wagga clinical school.